Candidiasis

Breast Cancer Drug May Beat Fungal Infection

...tors another way to help these critically ill patients." More information The U.S. Centers for Disease Control and Prevention has more about candidiasis . -- Kevin McKeever SOURCE: University of Rochester Medical Center, news release, July 20, 2...

Cimzia(R) (certolizumab pegol) Now Available for Self-Administration in Adult Patients With Moderate to Severe Crohn's Disease

...nt infection should be initiated prior to CIMZIA use. Invasive fungal infections, including histoplasmosis , coccidioidomycosis , candidiasis , aspergillosis , blastomycosis , and pneumocystosis . Patients with histoplasmosis or other invasive fungal infections may present wit...

Strativa Pharmaceuticals Provides Product Pipeline Update

...oSol Rx a total of $3.5 million for the completion of certain milestones. Loramyc (R) (miconazole Lauriad) for the treatment of oropharyngeal candidiasis (OPC) After preliminary review, the FDA has informed BioAlliance Pharma, Strativa's development partner, that the agency did not accept its NDA ...

Vusion Baby Bottom Line Report: Many Moms Don't Know that Their Babies' Irritated Skin Could Indicate a Severe Diaper Rash that Requires Medical Treatment

...diaper area by a baby's stool. A microscopic evaluation is needed to determine if a baby is suffering from Diaper Dermatitis complicated by documented candidiasis (DDCC). Treating DDCC, along with a regimen of cleansing and frequent diaper changes, may require the use of a prescription skin medication. Antibio...

New IDSA Clinical Practice Guidelines Recommend NOXAFIL(R) (Posaconazole) for Antifungal Prophylaxis in Certain High-Risk Patients

...ignancies with prolonged neutropenia from chemotherapy. In October 2006, the FDA approved NOXAFIL Oral Suspension for the treatment of oropharyngeal candidiasis (OPC), including infections refractory to itraconazole and/or fluconazole. OPC is a fungal infection of the mouth and throat caused by the yeast Candi...

FDA Approves Additional Indication for Astellas' MYCAMINE(R)

...MYCAMINE was approved in 2005 for the treatment of patients with esophageal candidiasis and is the only echinocandin approved for the prophylaxis of Candida infect...da Peritonitis and Abscesses; for the treatment of patients with Esophageal candidiasis and the prophylaxis of Candida Infections in patients undergoing Hematopoie...

New Anti Fungal Drug Eraxis as Good as the Older Medicine

...le but they can be life-threatening for people who are already ill and for babies who are born pre-term and tiny. The first compound used to treat candidiasis (yeast infection) was amphotericin B, which was effective but was limited by side effects. Over the years, less toxic alternatives were developed su...

Anti-Retroviral Therapies Associated with Reduced Infections in HIV-Infected Children

...15), herpes zoster (IR, 1.11), dermatophyte infections (IR, 0.88), and oral candidiasis (IR, 0.93). Infection rates were significantly lower than those reported in...l pneumonia (IR, 11.1), bacteremia (IR, 3.3), herpes zoster (IR, 2.9), oral candidiasis (IR, 1.2) and tuberculosis (IR, 0.2). “Despite these current advances...

Fight against Fungus - A new ray of hope

...ause a disease called candidiasis. Patients who are most vulnerable to candidiasis are those who are HIV-positive, those who have received organ transplants o... hospital set-up. The drug, which has not yet been approved for use in candidiasis patients, due to its high cost will be reserved for the sickest kinds of pa...

Cancer patients can now take once daily medication for infections

...ead and neck cancer who are undergoing radiation// therapy can now take once a day medication to fight oropharyngeal candidiasis. Oropharyngeal candidiasis is a fungal infection in the mouth caused by the yeast Candida. This condition is also called thrush. The symptoms of the disease are the formation of...

Candidiasis in Medical Technology

Strativa Pharmaceuticals Announces Phase III Results for Loramyc(R) to Treat Oropharyngeal Candidiasis

WOODCLIFF LAKE, N.J., April 21 /PRNewswire-FirstCall/ -- Strativa Pharmaceuticals, the proprietary products division of Par Pharmaceutical Companies, Inc. (NYSE: PRX ) today announced that its development partner, BioAlliance Pharma reported preliminary, top-line results for a Phase III study...

Strativa Pharmaceuticals Provides Product Pipeline Update

...oSol Rx a total of $3.5 million for the completion of certain milestones. Loramyc (R) (miconazole Lauriad) for the treatment of oropharyngeal candidiasis (OPC) After preliminary review, the FDA has informed BioAlliance Pharma, Strativa's development partner, that the agency did not accept its NDA ...

RHEI Pharmaceuticals Announces the Initiation of the Final Clinical Study for Approval of Tibozole in China

...duct will Fill Void in the Local Treatment of Oral candidiasis in Immunosuppressed Patients in China PLA...d create issues in patients." About Oral candidiasis Oral candidiasis, which is sometimes called t...ted mucosa of the mouth may appear inflamed. Oral candidiasis often occurs in immunocompromised people such as t...

Data on Telavancin and Micafungin Hold Promise of New Therapeutic Options in Fight Against Serious Infectious Disease

...o showed that in paediatric patients with invasive candidiasis or candidaemia, micafungin was as effective as sta...icensed in the US for the treatment of oesophageal candidiasis and for the prophylaxis of fungal infections cause...a large, phase III trial in patients with invasive candidiasis and candidaemia. ECCMID, Munich. Abstract number (...

Scientific Results Presented At ECCMID Demonstrate Well- Differentiated Profile of Basilea's Two Phase III Anti- infective Compounds

...al isavuconazole for the potential treatment of invasive fungal infections is in phase III testing in a global trial program in patients with invasive candidiasis including candidemia and patients with proven or probable aspergillosis. New microbiological surveillance data relevant for the treatment of candide...

Pacgen Announces Positive Results from Phase I/II Trial of Novel Antifungal Drug

...e PAC-113 dose and formulation. "For many immunocompromised patients oral candidiasis can be severe, impacting their ability to get appropriate nutrition. We are...aled corticosteroids for asthma or rhinitis are also at risk. Oropharyngeal candidiasis infection can cause great discomfort, and if not treated, can spread from t...

Candidiasis in Medical Dictionary

Candidiasis

Candidiasis or thrush is a fungal infection (mycosis) of any of the Candida species, of which Candida albicans is the most common. Candidiasis encompasses infections that range from superficial, such as oral thrush and... Candidiasis is a primary or secondary mycotic infection ...

Oral candidiasis

Oral candidiasis is an infection of yeast fungi of the genus Candida on the mucous membranes of the mouth. It is frequently caused by Candida albicans, or less commonly by Candida glabrata or Candida tropicalis. Oral thrush... ... 26 disease causes of Oral candidiasis , patient s...

Yeast infection

... candidiasis or thrush is a fungal infection (mycosis) of a...ies, of which Candida albicans is the most common. candidiasis encompasses infections that range from superfici... Infection ? A yeast infection , also known as candidiasis (pronounced: ... ...

Yeast Infections

...oms similar to those of a yeast infection . candidiasis is an infection caused by a group of microscopic...nsferred during sexual ... Candida yeast and candidiasis systemic intestinal yeast infections symptom...n names for yeast infections are vulvovaginal candidiasis (VVC) ... Genital yeast infection generally i...

Vaginal yeast infection

...sis, ... It's not clear whether vaginal yeast infections can be transferred during sexual ... Vaginal yeast infection or vulvovaginal candidiasis is a common cause of vaginal irritation. ... vaginal medications are available to treat yeast infection . ... ...

Thrush

... candidiasis or thrush is a fungal infection (mycosis) of a...ies, of which Candida albicans is the most common. candidiasis encompasses infections that range from superfici...acterized by small whitish Also known as oral candidiasis or monoliasis. Offers basic facts on the yeast ...

Skin infection

... is usually caused by bacteria that normally live on the skin , such ... Pseudomonas aeruginosa skin ; soft tissue; and bone infections ... candidiasis is by far the most common type of yeast infections in human skin . ... a-z list > yeast infection skin rash article " Healthcare Profe...

Pancreatic abscess

... abscess is a cavity of pus within the pancreas. ... pancreatic abscess , particularly if you have recently had a ... ... of pancreatic candidiasis are related to some form of pancreatic injury ... Aortoiliac graft infection and pancreatic abscess due to Candida albicans [letter] ... ...

Oral thrush

... Oral candidiasis is an infection of yeast fungi of the genus Ca...often treated with antifungal medications, ... candidiasis - oral ; Oral thrush . Causes. Thrush is cau...oes away on its own without medical treatment. candidiasis - oral ; Oral thrush . Causes. Thrush is cau...

Moniliasis

... encyclopedia (Redirected from Moniliasis ) ... candidiasis or thrush is a fungal infection (mycosis) of a...Us < Dental Services < Diseases and ... ORAL candidiasis ( MONILIASIS , THRUSH) ... Moniliasis sympto...Treatment Alternative treatment ... In the past candidiasis was referred to as moniliasis . Demographics ......

Candidiasis in Biological News

Discovery may lead to better Candidiasis drug

Oral biologists at the University at Buffalo have shown for the first time how histatin, the naturally occurring antifungal agent in saliva, kills the oral pathogen Candida albicans, the fungus responsible for most HIV-related oral infections. Researchers led by Mira Edgerton, D.D.S., Ph.D., dis...

Montreal researchers identify defects of immune cells

...s (HIV). These findings, revealed using a model of candidiasis in transgenic mice expressing HIV developed by the...lth and well-being. Of added concern, treatment of candidiasis in these patients is often complicated by strains ...tes primarily determine the susceptibility to oral candidiasis in transgenic mice expressing HIV-1 and developing...

Candidiasis in Biological Technology

FDA Clears Caspofungin (Cancidas(R)) Susceptibility Testing for TREK Sensititre(R) YeastOne(R) in Vitro Diagnostics (IVD) Product Line

...-inhibiting antifungal agents, caspofungin, is FDA-cleared for treatment of candidiasis in adults and pediatric patients. candidiasis is a fungal infection that can be life-threatening if it becomes systemic. ...

TVM Capital, Signet Healthcare Partners and Paul Capital Healthcare Enter into euro 26 Million Financing of SpePharm

... Germany, Italy, Benelux and the Nordic area where it is in the process of launching its first product, Loramyc(R), for the treatment of oropharyngeal candidiasis in immune-compromised patients. For more information about SpePharm, please visit the web site at http://www.spepharm.com . Contact Informatio...

Sagent Pharmaceuticals Launches Cefazolin for Injection, USP

...ion can be effective in reducing the incidence of certain surgical infections. The most common adverse effects may include mild nausea, diarrhea, oral candidiasis and pain or tenderness at the injection site. Less common adverse effects include vomiting, and rarely, pseudomembranous colitis. About Sagent Pharm...

Immtech and BioAlliance Sign Licensing Agreement for Pafuramidine

...es. The company has launched its first portfolio product (Loramyc(R)) in France, which is currently in Phase III clinical development in oropharyngeal candidiasis in the USA. In addition, two other innovative products are currently in phase III clinical trials: acyclovir Lauriad(R) in oral herpes (based on the s...

GlaxoSmithKline and Anacor Pharmaceuticals Form Alliance to Develop Systemic Antivirals and Antibiotics Based on Boron Chemistry

...osis. In addition, Anacor has a portfolio of other topical product candidates in development for the treatment of psoriasis, gingivitis, acne, vaginal candidiasis and tinea pedis. About GlaxoSmithKline GlaxoSmithKline, one of the world's leading research-based pharmaceutical and healthcare companies, is commit...

Anacor Files Registration Statement for Initial Public Offering

...2008. In addition, Anacor has a portfolio of other topical product candidates in development for the treatment of psoriasis, gingivitis, acne, vaginal candidiasis and tinea pedis. ...